Page 95 - SDIR5 Abstract book 21 12 2021.
P. 95

POSTER PRESENTATIONS



               P55



                 Antitumor features of dual COX-2 and 5-LOX inhibitors on melanoma and colon cancer cell
                                                        lines in vitro

                                 1
                                            1
                   Milan Marković , Jelena Erić , Robert Kuhnert , Evamarie Hey-Hawkins , Sanja Mijatović Danijela
                                                            2
                                                                                  2
                                                                                                 1
                                                      Maksimović-Ivanić 1
                   1 Institute for Biological Research "Siniša Stanković", National Institute of Republic of Serbia, Department for
                                          Immunology, Belgrade University, Belgrade, Serbia
                   2 Faculty of Chemistry and Mineralogy, Institute of Inorganic Chemistry, Leipzig University, Leipzig, Germany

               Background:  Chronic  inflammation  inside  brain,  kidney,  liver,  melanoma,  and  colon  tumors  is  in  tight
               connection with their growth and progression. In that context expression of the enzyme cyclooxygenase,
               COX-2, takes a pivotal role as a link between inflammation and cancerogenesis promoting cell proliferation
               at the same time. Furthermore, lipooxygenase-5 (5-LOX) also provokes cell division, and viability of many
               inflammation-related  cancers.  Since  both  enzymes  are  linked  to  arachidonic  acid  metabolism,  dual
               inhibition  of  COX-2/5-LOX  can  be  a  promising  approach  in  supression  of  tumor  growth.  Material  and
               methods:  We  have  therefore  examined  the  effect  of  the  synthesized  COX-2/5-LOX  dual  inhibitors
               C₁₃H₂₅B₁₀O₂NS (U), C₁₆H₃₀B₁₀O₂S (V), and C₁₈H₂₇B₁₀IO₂S (W) on the viability of melanoma (B16-F1, B16-F10,
               A375) as well as colon cancer lines (HCT116, SW480, CT26). All cells were treated in a dose-dependent
               manner (dose range 100µM to 1.5µM) with each dual inhibitor. Cell viability was measured  by MTT and
               CV. Results: The results show that compound W was the most selective against CT26 cells with an IC50
               value of 17.9µM which is an 8.7 times lower dose than on mouse peritoneal macrophages (155.7µM).
               Cytofluorimetric analysis revealed that compound W slightly inhibits proliferation of CT26 cells in culture,
               and causes apoptosis independent from phosphatidyl serine (PS) inversion, as well as caspase activity.
               Furthermore, treatment with compound W strongly upregulates production of reactive oxygen/nitrogen
               species by CT26 cells. Conclusion: Taken together, the inhibition of both enzymes COX-2 and 5-LOX in CT26
               cell  line  leads  to  limited  tumor  cell  growth,  and  might  also  have  a  beneficial  influence  on  the  tumor
               microenvironment.
               Keywords: Inflammation, cancer cells, COX-2, 5-LOX, dual inhibitor
               Acknowledgements: Ministry  of  Education,  Science  and Technological  development  of  the  Republic  of
               Serbia No. 451-03-9/2021-14/200007 and Bilateral project with FR Germany (451-02-00127/2020-09/3).














                                                             82
   90   91   92   93   94   95   96   97   98   99   100